AI assistant
CONTROL BIONICS LIMITED — Share Issue/Capital Change 2025
Feb 25, 2025
64611_rns_2025-02-25_0384f4fe-afbd-4bfc-bd54-5f3036d2c511.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
==> picture [177 x 63] intentionally omitted <==
26 February 2025
Notice Pursuant to Section 708A(5)(e) of the Corporations Act
Control Bionics Limited ACN 115 465 462 (the Company ) gives notice under section 708A(5)(e) of the Corporations Act as follows:
-
(a) On 26 February 2025, the Company issued 42,624,175 fully paid ordinary shares in the Company.
-
(b) The shares were issued without disclosure under Part 6D.2 of the Corporations Act.
-
(c)
-
As at the date of this notice the Company has complied with:
-
(i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and
-
(ii) Section 674 of the Corporations Act.
-
-
(d) As at the date of this notice there is no excluded information required to be disclosed under section 708A(6)(e) of the Corporations Act.
Brett Crowley Company Secretary
Control Bionics Limited Registered Office: Level 4, 11-13 Pearson St, Cremorne, Victoria, 3121, Australia T: +61 3 9897 3576 W: www.controlbionics.com
ABN: 45 115 465 462